Fortaleza Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-35
| Closed | -$2.37K | – | 186 |
|
2016
Q3 | $2.37K | Hold |
35
| – | – | ﹤0.01% | 192 |
|
2016
Q2 | $2K | Sell |
35
-22,590
| -100% | -$1.29M | ﹤0.01% | 182 |
|
2016
Q1 | $1.42M | Buy |
22,625
+7,895
| +54% | +$496K | 0.9% | 49 |
|
2015
Q4 | $1.39M | Buy |
14,730
+1,365
| +10% | +$129K | 0.84% | 49 |
|
2015
Q3 | $1.07M | Hold |
13,365
| – | – | 0.76% | 48 |
|
2015
Q2 | $1.6M | Sell |
13,365
-6,780
| -34% | -$813K | 0.96% | 46 |
|
2015
Q1 | $2.1M | Sell |
20,145
-6,715
| -25% | -$701K | 1.19% | 26 |
|
2014
Q4 | $2.61M | Sell |
26,860
-20,310
| -43% | -$1.97M | 1.19% | 17 |
|
2014
Q3 | $3.68M | Buy |
47,170
+33,830
| +254% | +$2.64M | 1.73% | 4 |
|
2014
Q2 | $843K | Buy |
13,340
+2,710
| +25% | +$171K | 0.39% | 113 |
|
2014
Q1 | $714K | Sell |
10,630
-5,025
| -32% | -$338K | 0.36% | 102 |
|
2013
Q4 | $1.01M | Buy |
15,655
+5,401
| +53% | +$347K | 0.51% | 71 |
|
2013
Q3 | $656K | Buy |
+10,254
| New | +$656K | 0.34% | 117 |
|